High concentrations of membrane-fed ivermectin are required for substantial lethal and sublethal impacts on Aedes aegypti
暂无分享,去创建一个
[1] Hannah C. Slater,et al. Ivermectin as a novel complementary malaria control tool to reduce incidence and prevalence: a modelling study. , 2020, The Lancet. Infectious diseases.
[2] Duolao Wang,et al. Pharmacokinetics‐Pharmacodynamics of High‐Dose Ivermectin with Dihydroartemisinin‐Piperaquine on Mosquitocidal Activity and QT‐Prolongation (IVERMAL) , 2018, Clinical pharmacology and therapeutics.
[3] Duolao Wang,et al. Human Direct Skin Feeding Versus Membrane Feeding to Assess the Mosquitocidal Efficacy of High-Dose Ivermectin (IVERMAL Trial) , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] Xiaonong Zhou,et al. Antivirus effectiveness of ivermectin on dengue virus type 2 in Aedes albopictus , 2018, PLoS neglected tropical diseases.
[5] O. Faye,et al. Worldwide survey reveals lower susceptibility of African Aedes aegypti mosquitoes to diverse strains of Zika virus , 2018, bioRxiv.
[6] Teun Bousema,et al. Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double-blind, placebo-controlled trial. , 2018, The Lancet. Infectious diseases.
[7] Kevin C. Kobylinski,et al. Promising approach to reducing Malaria transmission by ivermectin: Sporontocidal effect against Plasmodium vivax in the South American vectors Anopheles aquasalis and Anopheles darlingi , 2018, PLoS Neglected Tropical Diseases.
[8] S. Weaver,et al. Zika, Chikungunya, and Other Emerging Vector-Borne Viral Diseases. , 2018, Annual review of medicine.
[9] C. Moyes,et al. Aedes Mosquitoes and Aedes-Borne Arboviruses in Africa: Current and Future Threats , 2018, International journal of environmental research and public health.
[10] Kevin C. Kobylinski,et al. Ivermectin susceptibility, sporontocidal effect, and inhibition of time to re-feed in the Amazonian malaria vector Anopheles darlingi , 2017, Malaria Journal.
[11] G. Killeen,et al. Informing new or improved vector control tools for reducing the malaria burden in Tanzania: a qualitative exploration of perceptions of mosquitoes and methods for their control among the residents of Dar es Salaam , 2017, Malaria Journal.
[12] Kevin C. Kobylinski,et al. Ivermectin susceptibility and sporontocidal effect in Greater Mekong Subregion Anopheles , 2017, Malaria Journal.
[13] C. Moyes,et al. Contemporary status of insecticide resistance in the major Aedes vectors of arboviruses infecting humans , 2017, PLoS neglected tropical diseases.
[14] Stella T. Kessy,et al. Ivermectin-treated cattle reduces blood digestion, egg production and survival of a free-living population of Anopheles arabiensis under semi-field condition in south-eastern Tanzania , 2017, Malaria Journal.
[15] C. Chaccour,et al. Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety , 2017, Malaria Journal.
[16] John M. Marshall,et al. Measuring, manipulating and exploiting behaviours of adult mosquitoes to optimise malaria vector control impact , 2017, BMJ Global Health.
[17] C. Chaccour,et al. Oral, Slow-Release Ivermectin: Biting Back at Malaria Vectors. , 2017, Trends in parasitology.
[18] Scott C Weaver,et al. Epidemic arboviral diseases: priorities for research and public health. , 2017, The Lancet. Infectious diseases.
[19] M. Prudêncio,et al. Inhibition of Plasmodium Liver Infection by Ivermectin , 2016, Antimicrobial Agents and Chemotherapy.
[20] Q. Bassat,et al. Filling gaps on ivermectin knowledge: effects on the survival and reproduction of Anopheles aquasalis, a Latin American malaria vector , 2016, Malaria Journal.
[21] J. Hemingway,et al. Averting a malaria disaster: will insecticide resistance derail malaria control? , 2016, The Lancet.
[22] H. Ranson,et al. Insecticide Resistance in African Anopheles Mosquitoes: A Worsening Situation that Needs Urgent Action to Maintain Malaria Control. , 2016, Trends in parasitology.
[23] Anthony S Fauci,et al. Zika Virus in the Americas--Yet Another Arbovirus Threat. , 2016, The New England journal of medicine.
[24] G. Killeen,et al. Mind the gap: residual malaria transmission, veterinary endectocides and livestock as targets for malaria vector control , 2016, Malaria Journal.
[25] T. Lefèvre,et al. Administration of ivermectin to peridomestic cattle: a promising approach to target the residual transmission of human malaria , 2015, Malaria Journal.
[26] R. Poché,et al. Treatment of livestock with systemic insecticides for control of Anopheles arabiensis in western Kenya , 2015, Malaria Journal.
[27] A. Sivan,et al. Host-feeding pattern of Aedes aegypti and Aedes albopictus (Diptera: Culicidae) in heterogeneous landscapes of South Andaman, Andaman and Nicobar Islands, India , 2015, Parasitology Research.
[28] C. Snow,et al. Characterization of the target of ivermectin, the glutamate-gated chloride channel, from Anopheles gambiae , 2015, The Journal of Experimental Biology.
[29] C. Chaccour,et al. Screening for an ivermectin slow-release formulation suitable for malaria vector control , 2015, Malaria Journal.
[30] P. E. Simonsen,et al. Differential effect of human ivermectin treatment on blood feeding Anopheles gambiae and Culex quinquefasciatus , 2015, Parasites & Vectors.
[31] P. E. Simonsen,et al. Differential effect of human ivermectin treatment on blood feeding Anopheles gambiae and Culex quinquefasciatus , 2015, Parasites & Vectors.
[32] Teun Bousema,et al. Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[33] E. Ottesen,et al. Global Programme to Eliminate Lymphatic Filariasis: The Processes Underlying Programme Success , 2014, PLoS neglected tropical diseases.
[34] Kevin C. Kobylinski,et al. Evaluation of ivermectin mass drug administration for malaria transmission control across different West African environments , 2014, Malaria Journal.
[35] Kevin C. Kobylinski,et al. Rationale for the coadministration of albendazole and ivermectin to humans for malaria parasite transmission control. , 2014, The American journal of tropical medicine and hygiene.
[36] Q. Bassat,et al. Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination , 2013, Malaria Journal.
[37] John S. Brownstein,et al. The global distribution and burden of dengue , 2013, Nature.
[38] C. Simmons,et al. Aedes aegypti (L.) survival after exposure to ivermectin. , 2013, The Southeast Asian journal of tropical medicine and public health.
[39] Kevin C Kobylinski,et al. Ivermectin inhibits the sporogony of Plasmodium falciparum in Anopheles gambiae , 2012, Malaria Journal.
[40] Alicia M. Hanson,et al. Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug. , 2012, The Journal of antimicrobial chemotherapy.
[41] E. Walker,et al. Lethal and Sublethal Effects of Avermectin/Milbemycin Parasiticides on the African Malaria Vector, Anopheles arabiensis , 2012, Journal of medical entomology.
[42] B. Foy,et al. The Effect of Ivermectin in Seven Strains of Aedes aegypti (Diptera: Culicidae) Including a Genetically Diverse Laboratory Strain and Three Permethrin Resistant Strains , 2012, Journal of medical entomology.
[43] Kevin C. Kobylinski,et al. Endectocides for malaria control. , 2011, Trends in parasitology.
[44] Kevin C. Kobylinski,et al. Ivermectin mass drug administration to humans disrupts malaria parasite transmission in Senegalese villages. , 2011, The American journal of tropical medicine and hygiene.
[45] Kevin C. Kobylinski,et al. Mass drug administration of ivermectin in south-eastern Senegal reduces the survivorship of wild-caught, blood fed malaria vectors , 2010, Malaria Journal.
[46] Massamba Sylla,et al. The effect of oral anthelmintics on the survivorship and re-feeding frequency of anthropophilic mosquito disease vectors. , 2010, Acta tropica.
[47] Achim Hoerauf,et al. Lymphatic filariasis and onchocerciasis , 2010, The Lancet.
[48] J. Lines,et al. Effect of ivermectin on Anopheles gambiae mosquitoes fed on humans: the potential of oral insecticides in malaria control. , 2010, The Journal of infectious diseases.
[49] H. Delatte,et al. Blood-feeding behavior of Aedes albopictus, a vector of Chikungunya on La Réunion. , 2010, Vector borne and zoonotic diseases.
[50] E. Walker,et al. Toxicity of bloodmeals from ivermectin-treated cattle to Anopheles gambiae s.l. , 2009, Annals of tropical medicine and parasitology.
[51] J. G. Vieitez,et al. The Pharmacokinetics and Interactions of Ivermectin in Humans—A Mini-review , 2008, The AAPS Journal.
[52] C. Apperson,et al. Host-Feeding Patterns of Aedes albopictus (Diptera: Culicidae) in Relation to Availability of Human and Domestic Animals in Suburban Landscapes of Central North Carolina , 2006, Journal of medical entomology.
[53] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[54] M. Alpers,et al. Mass treatment with ivermectin for filariasis control in Papua New Guinea: impact on mosquito survival , 1999, Medical and veterinary entomology.
[55] D. Cully,et al. Identification of a Drosophila melanogaster Glutamate-gated Chloride Channel Sensitive to the Antiparasitic Agent Avermectin* , 1996, The Journal of Biological Chemistry.
[56] C. Meek,et al. Effects of ivermectin in canine blood on Anopheles quadrimaculatus, Aedes albopictus and Culex salinarius. , 1993, Journal of the American Mosquito Control Association.
[57] M. Wilson. Avermectins in arthropod vector management - prospects and pitfalls. , 1993, Parasitology today.
[58] W. Reeves,et al. Blood-feeding habits of four species of mosquito found in Hawaii. , 1970, The American journal of tropical medicine and hygiene.